We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Atorvastatin on Adiponectin Levels and Insulin Sensitivity In Hypercholesterolemic Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00745836
First Posted: September 3, 2008
Last Update Posted: September 3, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Gachon University Gil Medical Center
September 2, 2008
September 3, 2008
September 3, 2008
January 2005
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Effects of Atorvastatin on Adiponectin Levels and Insulin Sensitivity In Hypercholesterolemic Patients
Not Provided
High dose atorvastatin may worsen insulin sensitivity.
Not Provided
Interventional
Phase 4
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Hypercholesterolemia
Drug: statin
Experimental: atorvastatin 10 mg, 80 mg
Intervention: Drug: statin
Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Shin EK. Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol. 2010 Mar 23;55(12):1209-16. doi: 10.1016/j.jacc.2009.10.053.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
August 2008
Not Provided

Inclusion Criteria:

  • hypercholesterolemia

Exclusion Criteria:

  • chronic renal disease
Sexes Eligible for Study: All
25 Years to 80 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT00745836
GMC-200508
Yes
Not Provided
Not Provided
Not Provided
Gachon University Gil Medical Center
Not Provided
Not Provided
Gachon University Gil Medical Center
September 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP